Pages that link to "Q39918061"
Jump to navigation
Jump to search
The following pages link to Evidence for genetic heterogeneity in D-2-hydroxyglutaric aciduria (Q39918061):
Displaying 25 items.
- Isocitrate dehydrogenase mutations: new opportunities for translational research (Q27001014) (← links)
- IDH mutations in tumorigenesis and their potential role as novel therapeutic targets (Q27692015) (← links)
- IDH2 mutations in patients with D-2-hydroxyglutaric aciduria (Q28293455) (← links)
- Succinic Semialdehyde Dehydrogenase: Biochemical–Molecular–Clinical Disease Mechanisms, Redox Regulation, and Functional Significance (Q28743137) (← links)
- Clinical review of genetic epileptic encephalopathies (Q30537230) (← links)
- Isocitrate dehydrogenase 1 and 2 mutations in cancer: alterations at a crossroads of cellular metabolism (Q33965102) (← links)
- D2HGDH regulates alpha-ketoglutarate levels and dioxygenase function by modulating IDH2 (Q35889016) (← links)
- Progress in understanding 2‐hydroxyglutaric acidurias (Q36072068) (← links)
- Sensitive Determination of Onco-metabolites of D- and L-2-hydroxyglutarate Enantiomers by Chiral Derivatization Combined with Liquid Chromatography/Mass Spectrometry Analysis (Q36150279) (← links)
- What a difference a hydroxyl makes: mutant IDH, (R)-2-hydroxyglutarate, and cancer (Q36832167) (← links)
- Prognostic significance of 2-hydroxyglutarate levels in acute myeloid leukemia in China (Q37240701) (← links)
- A small molecule inhibitor of mutant IDH2 rescues cardiomyopathy in a D-2-hydroxyglutaric aciduria type II mouse model. (Q37341931) (← links)
- D-2-hydroxyglutarate produced by mutant IDH2 causes cardiomyopathy and neurodegeneration in mice (Q37631229) (← links)
- Disruption of mitochondrial homeostasis in organic acidurias: insights from human and animal studies (Q37830368) (← links)
- Altered cancer cell metabolism in gliomas with mutant IDH1 or IDH2 (Q37955769) (← links)
- ω-Amidase: an underappreciated, but important enzyme in L-glutamine and L-asparagine metabolism; relevance to sulfur and nitrogen metabolism, tumor biology and hyperammonemic diseases. (Q38563900) (← links)
- HOT mutation screening in human glioblastomas (Q38747962) (← links)
- L2hgdh Deficiency Accumulates l-2-Hydroxyglutarate with Progressive Leukoencephalopathy and Neurodegeneration. (Q38991165) (← links)
- A lymphoblast model for IDH2 gain-of-function activity in d-2-hydroxyglutaric aciduria type II: Novel avenues for biochemical and therapeutic studies (Q39710974) (← links)
- Isocitrate dehydrogenase 1/2 mutational analyses and 2‐hydroxyglutarate measurements in Wilms tumors (Q54393106) (← links)
- Cerebral Organic Acid Disorders and Other Disorders of Lysine Catabolism (Q56094874) (← links)
- d-2-Hydroxyglutarate dehydrogenase plays a dual role in l-serine biosynthesis and d-malate utilization in the bacterium (Q57022034) (← links)
- Papillary thyroid carcinoma shows elevated levels of 2-hydroxyglutarate (Q82467819) (← links)
- Wild-Type IDH Enzymes as Actionable Targets for Cancer Therapy (Q90208059) (← links)
- D-2-hydroxyglutaric aciduria Type I: Functional analysis of D2HGDH missense variants (Q92600421) (← links)